Ryan Specialty Holdings, Inc.
NYSE:RYANInsurance - Specialty
-$0.59 today
- Market cap
- $5.79B
- Beta
- 0.64
- P/E (TTM)
- 34.2
- EPS (TTM)
- $1.02
- Dividend yield
- 1.44%
Volume 1.38M
Average 2.89M
RYAN Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Ryan Specialty Holdings, Inc.NYSE: RYAN
Accumulated OCI · Q2 FY2026 · quarter ended Jun 2026
Accumulated OCI rises 8.0% from a year ago
Accumulated OCI stood at $16.59M at the end of Q2 FY2026, up 8.0% from a year earlier and up 76.7% from the prior quarter. Over 3 fiscal years it compounded at +31.9% a year.
Context
- Accumulated OCI amounted to 0.1% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Accumulated OCI increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether Accumulated OCI keeps rising in the next quarterly balance sheet after a +8.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- 13.85M USD
- Year-over-year change
- +870.9%
- 4-year CAGR
- +68.6%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 13.85M | +870.9% |
| FY2024 | 2024-12-31 | (1.8M) | -158.4% |
| FY2023 | 2023-12-31 | 3.08M | -49.0% |
| FY2022 | 2022-12-31 | 6.04M | +252.1% |
| FY2021 | 2021-12-31 | 1.71M | — |
Accumulated OCI vs competitors
How RYAN compares with its peers on the latest reported figures
- RYAN's Jun 2026 Accumulated OCI of $16.59M is the highest of the 9 companies compared; the peer median is -$478.73M.
- Its year-over-year change of +8.0% is the highest of 9, against a peer median of -111.0%.
- Accumulated OCI amounts to 0.1% of total assets for RYAN, versus a peer median of 1.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $16.59M | +8.0% | +31.9% | 0.1% | |
| Jun 2026 | -$13.05M | +5.2% | — | 0.0% | |
| Sep 2026 | -$325.75M | -104.6% | — | 5.1% | |
| Sep 2026 | -$359.65M | -117.4% | — | 4.8% | |
| Jun 2026 | -$413M | -760.4% | — | 0.5% | |
| Sep 2026 | -$544.45M | -140.2% | — | 1.0% | |
| Sep 2026 | -$709.2M | -147.8% | — | 3.9% | |
| Jun 2026 | -$1.95B | +5.6% | — | 1.1% | |
| Jun 2026 | -$4.58B | -4.2% | — | 1.1% | |
| Peer median (excluding RYAN) | -$478.73M | -111.0% | — | 1.1% | |
Competitors are the stored peer set for RYAN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 386.96M | 992.72M | 838.79M | 540.2M | 158.32M |
| Short-term Investments | 0 | 0 | 0 | 13.94M | 0 |
| Net Receivables | 2.6B | 2.87B | 3.46B | 4.17B | 488.95M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | (76.55M) |
| Total Current Assets | 3.04B | 3.91B | 4.35B | 4.81B | 647.27M |
| Property, Plant & Equipment (Net) | 100.16M | 175.14M | 170.14M | 183.47M | 199.94M |
| Goodwill | 1.31B | 1.31B | 1.65B | 2.65B | 3.23B |
| Intangible Assets | 573.93M | 486.44M | 610.67M | 1.48B | 119.62M |
| Long-term Investments | 45.42M | 38.51M | 46.1M | 70.88M | 109.98M |
| Tax Assets | 382.75M | 396.81M | 383.82M | 448.29M | 310.14M |
| Other Non-current Assets | 10.79M | 56.99M | 39.31M | 18.59M | 5.95B |
| Total Non-current Assets | 2.42B | 2.47B | 2.9B | 4.84B | 9.92B |
| Total Assets | 5.46B | 6.38B | 7.25B | 9.65B | 10.56B |
| Account Payables | 0 | 0 | 0 | 0 | 217.3M |
| Short-term Debt | 23.47M | 30.59M | 35.38M | 51.73M | 60.19M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 631K | 562K | 55K | 39.92M | (217.3M) |
| Total Current Liabilities | 433.56M | 414.31M | 501.28M | 649.45M | 86.17M |
| Long-term Debt | 1.57B | 1.95B | 1.94B | 3.23B | 3.29B |
| Deferred Tax Liabilities | 631K | 562K | 55K | 39.92M | 49.83M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 2.79B | 3.05B | 3.67B | 4.47B | 5.73B |
| Total Non-current Liabilities | 4.43B | 5.15B | 5.77B | 7.9B | 9.22B |
| Total Liabilities | 4.86B | 5.57B | 6.27B | 8.55B | 9.31B |
| Common Stock | 259K | 259K | 261K | 261K | 265K |
| Retained Earnings | (7.06M) | 53.99M | 114.42M | 122.94M | 120.35M |
| Accumulated OCI | 1.71M | 6.04M | 3.08M | (1.8M) | 13.85M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 251M | 339.41M | 419.89M | 470.62M | 605.98M |
| Total Equity | 594.78M | 817.81M | 979.64M | 1.1B | 1.25B |
| Total Debt | 1.68B | 2.16B | 2.16B | 3.46B | 3.53B |
| Net Debt | 1.3B | 1.16B | 1.32B | 2.92B | 3.37B |
Ryan Specialty Holdings, Inc.
NYSE:RYAN
Intrinsic Alpha fair value
Locked
Current Price
$48.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.